| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Joshua A Boyce | |
| P2860 | cites work | Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 |
| Mast Cell: A Multi-Functional Master Cell | Q26771463 | ||
| Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma | Q28188506 | ||
| Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis | Q28194143 | ||
| Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease | Q28194657 | ||
| Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells | Q28194899 | ||
| Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma | Q28196323 | ||
| Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. | Q30279219 | ||
| Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature | Q34441715 | ||
| Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease | Q34892917 | ||
| Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation | Q35545787 | ||
| Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps | Q36062767 | ||
| Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway | Q36119388 | ||
| Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists | Q36370341 | ||
| T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. | Q36376120 | ||
| Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells | Q36711106 | ||
| Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis | Q37138334 | ||
| The cytokine interleukin-33 mediates anaphylactic shock | Q37238924 | ||
| Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes | Q37240446 | ||
| Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics | Q39811129 | ||
| Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease | Q41146048 | ||
| Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses | Q41864224 | ||
| Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. | Q42484997 | ||
| KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma | Q43575814 | ||
| Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. | Q45986027 | ||
| Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics | Q46240727 | ||
| Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma | Q46363432 | ||
| Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. | Q47669026 | ||
| Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma | Q48020876 | ||
| Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. | Q49126882 | ||
| The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. | Q51021309 | ||
| Aspirin-Exacerbated Respiratory Disease--New Prime Suspects. | Q51550145 | ||
| Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease. | Q51574958 | ||
| Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease. | Q51699073 | ||
| Leukotriene E4 induces airflow obstruction and mast cell activation via the CysLT1 receptor. | Q52727846 | ||
| The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation | Q57023002 | ||
| The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin | Q57240791 | ||
| Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease (AERD) | Q58556061 | ||
| Allergic inflammatory memory in human respiratory epithelial progenitor cells | Q59050242 | ||
| Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α | Q59092114 | ||
| Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects | Q67915846 | ||
| Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA) | Q67986774 | ||
| Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma | Q69352841 | ||
| Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro | Q70469921 | ||
| Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers | Q70629252 | ||
| Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects | Q70839055 | ||
| Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma | Q70906164 | ||
| Preferential generation of prostaglandin D2 by rat and human mast cells | Q71578709 | ||
| Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma | Q72352958 | ||
| Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma | Q72964940 | ||
| Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium | Q73227991 | ||
| The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects | Q73442941 | ||
| Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma | Q74289995 | ||
| Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs | Q74454826 | ||
| Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics | Q74490010 | ||
| Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma | Q77451452 | ||
| Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells | Q80736011 | ||
| Omalizumab can inhibit respiratory reaction during aspirin desensitization | Q88734764 | ||
| COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity | Q90288923 | ||
| Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism | Q91142640 | ||
| Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial | Q93056163 | ||
| P433 | issue | 4 | |
| P921 | main subject | aspirin | Q18216 |
| mast cell | Q191989 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 875-881 | |
| P577 | publication date | 2019-10-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function | |
| P478 | volume | 144 |
| Q90108933 | Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial |
| Q104496576 | Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease |
Search more.